Positive global health outcomes are often contingent on more than just great science, as knowledge sharing is also a fundamental part of achieving public health goals. With drug resistance on the rise for many pathogens once thought well managed clinically, scientists are looking toward the development of new vaccines to help reduce morbidity and mortality for many global diseases. Collaboration between academia, industry, suppliers, and government organizations is crucial for the successful development of these vaccines, as these intellectual exchanges help accelerate production timelines, reduce costs, and increase chances of bringing an essential vaccine to market.

The experts from the M Lab™ Collaboration Centers at Merck are no strangers to knowledge sharing and have been involved in supporting a number of successful vaccine development projects. In this GENcast, we talk to a diverse group of public health scientists and discuss their vaccine development projects and how the M Lab Collaboration Centers were able to assist them toward positive outcomes.

View Transcript of This Podcast


Bart Fryszczyn
Process Development Scientist

Victor Abramant
Process Development Scientist

Luciana Cezar De Cerqueira Leite
Director of Vaccine Development Library
Butantan Institute

Maria Elena Bottazzi
Co-Director, Texas Children’s Hospital Center for Vaccine Development
Baylor College of Medicine

Zhuyun Liu
Director Process Development Unit
Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine

The post Vaccinating the World One Collaboration at a Time appeared first on GEN – Genetic Engineering and Biotechnology News.